乳腺癌女性化疗前生育力保存:系统综述与Meta分析
该Meta分析纳入22项研究,评估乳腺癌女性在性腺毒性治疗前接受不同卵巢刺激方案的生育力保存结局。随机启动卵巢刺激获取的卵母细胞数与常规方案相当;两个卵巢刺激周期的获卵总数显著高于一个周期;来曲唑联合他莫昔芬对获卵数影响与未联合者相似,但来曲唑组峰值血清雌二醇显著更低。
要点
- 随机启动卵巢刺激可缩短等待时间,获卵数与常规方案相当。
- 两个卵巢刺激周期的获卵总数显著高于一个周期(均差7.91,95%CI 3.42–12.40)。
- 来曲唑组峰值血清雌二醇显著低于未用来曲唑组(均差-1.22,95%CI -1.42至-1.02)。
核心结论
- 随机启动方案可缩短等待卵巢刺激的时间,两个卵巢刺激周期及联合来曲唑可带来更理想的结局。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase和Cochrane Library,纳入22项比较乳腺癌女性不同卵巢刺激方案生育力保存结局的研究。
主要发现
- 随机启动卵巢刺激获取的卵母细胞数与常规方案相当。
- 两个卵巢刺激周期的获卵总数显著高于一个周期(均差7.91,95%CI 3.42–12.40)。
- 来曲唑联合他莫昔芬对获卵数的影响与未联合者相似。
- 来曲唑组峰值血清雌二醇显著低于未用来曲唑组(均差-1.22,95%CI -1.42至-1.02)。
临床怎么用
- 对需尽快开始性腺毒性治疗的乳腺癌女性,可考虑随机启动卵巢刺激以缩短等待时间。
- 在条件允许时可考虑两个卵巢刺激周期以增加获卵总数。
- 联合来曲唑可在不显著影响获卵数的同时降低峰值血清雌二醇。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The preservation of fertility in women of childbearing age with breast cancer is challenging because the time for ovarian stimulation is restricted and only a limited number of oocytes can be retrieved before gonadotoxic therapies. The aim of this meta-analysis was to evaluate the fertility preservation outcomes after ovarian stimulation with various protocols in women with breast cancer. PubMed, Embase and the Cochrane Library were searched. Twenty-two studies comparing the outcomes of women with breast cancer receiving random-start ovarian stimulation or conventional protocol; single or double ovarian stimulation cycles; and coadministration of aromatase inhibitors or tamoxifen were included. Random-start ovarian stimulation resulted in a comparable number of retrieved oocytes to the conventional protocol. Two ovarian stimulation cycles had significantly higher numbers of total retrieved oocytes than one cycle (mean difference 7.91, 95% confidence interval [CI] 3.42 to 12.40). Coadministration of letrozole and tamoxifen showed similar results for retrieved oocytes to those without. A significantly lower peak serum oestradiol concentration was observed in letrozole-based groups than in letrozole-free groups (mean difference -1.22; 95% CI -1.42 to -1.02). In conclusion, this study indicated that implementing random-start protocols to shorten the duration of waiting for ovarian stimulation, applying two ovarian stimulation cycles, and coadministration of letrozole can lead to more desirable outcomes.
引用
- Chen CN, Chang LT, Chen CH, et al. Fertility preservation for women with breast cancer before chemotherapy: a systematic review and meta-analysis. Reprod Biomed Online. 2021. PMID: 34656436. doi:10.1016/j.rbmo.2021.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。